Mayo Clinic launches clinical analytics platform with nference; WuXi buys German plant from Bayer
→ Mayo Clinic is opening up its sprawling clinical database to nference, the Cambridge, MA-based AI startup it’s long partnered with and recently backed in a $60 million round. The project aims to digitize 25 million tissue slides within the next 2 to 2.5 years, FierceBiotech reported, in addition to annotating, linking and tagging written physician notes. After sorting through the data, nference will use the platform to identify new targets and biomarkers as well as apply it in clinical trial recruitment and real-world evidence generation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.